PATENT CLAIM ANALYSIS

Application Number: 15911713
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["506", "009000"]

Abstract:
Described are three-dimensional, engineered, biological breast tissues, adipose tissues, and tumor models, including breast cancer models.

Claim (Index 33):
A method of fabricating a three-dimensional, engineered, biological breast cancer model, the method comprising:\n a. preparing a stromal bio-ink, the stromal bio-ink comprising a plurality of stromal cell types, the stromal cell types comprising: an extrusion compound, human mammary fibroblasts, human endothelial cells, and human adipocytes; b. preparing a tumor bio-ink, the tumor bio-ink comprising: an extrusion compound and a breast cancer cell type; c. depositing the stromal bio-ink and the tumor bio-ink such that the tumor bio-ink is embedded in the stromal bio-ink and in contact with the stromal bio-ink on all sides; and d. maturing the deposited bio-ink in a cell culture media to remove the extrusion compound and allow the cells to cohere to form a three-dimensional, engineered, biological breast cancer model.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 90.0
- Lexical Diversity: 1.46667
- Patent Class: 506.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14678392', '14876659', '15259264', '14295226', '13841430']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6226684503129717
- 35 USC 102 Novelty (BERT): 0.66018564176742
- Combined Prediction Score: 0.6264201694584165
- Mean Citation Score: 478.838696
- Max Citation Score: 736.5769700000003
- Similarity Product: 606.3381228976311

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test